These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carboxylate ions are strong allosteric ligands for the HisB10 sites of the R-state insulin hexamer. Huang ST; Choi WE; Bloom C; Leuenberger M; Dunn MF Biochemistry; 1997 Aug; 36(32):9878-88. PubMed ID: 9245420 [TBL] [Abstract][Full Text] [Related]
3. Half-site reactivity, negative cooperativity, and positive cooperativity: quantitative considerations of a plausible model. Bloom CR; Kaarsholm NC; Ha J; Dunn MF Biochemistry; 1997 Oct; 36(42):12759-65. PubMed ID: 9335532 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions. Rahuel-Clermont S; French CA; Kaarsholm NC; Dunn MF; Chou CI Biochemistry; 1997 May; 36(19):5837-45. PubMed ID: 9153424 [TBL] [Abstract][Full Text] [Related]
5. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review. Dunn MF Biometals; 2005 Aug; 18(4):295-303. PubMed ID: 16158220 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the allosteric properties of the Co(II)- and Zn(II)-substituted insulin hexamers. Bloom CR; Wu N; Dunn A; Kaarsholm NC; Dunn MF Biochemistry; 1998 Aug; 37(31):10937-44. PubMed ID: 9692986 [TBL] [Abstract][Full Text] [Related]
7. The allosteric transition of the insulin hexamer is modulated by homotropic and heterotropic interactions. Choi WE; Brader ML; Aguilar V; Kaarsholm NC; Dunn MF Biochemistry; 1993 Nov; 32(43):11638-45. PubMed ID: 8218231 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the R-state insulin hexamer and its derivatives. The hexamer is stabilized by heterotropic ligand binding interactions. Brader ML; Kaarsholm NC; Lee RW; Dunn MF Biochemistry; 1991 Jul; 30(27):6636-45. PubMed ID: 2065051 [TBL] [Abstract][Full Text] [Related]
9. Structural asymmetry and half-site reactivity in the T to R allosteric transition of the insulin hexamer. Brzović PS; Choi WE; Borchardt D; Kaarsholm NC; Dunn MF Biochemistry; 1994 Nov; 33(44):13057-69. PubMed ID: 7947711 [TBL] [Abstract][Full Text] [Related]
10. Raman signatures of ligand binding and allosteric conformation change in hexameric insulin. Ferrari D; Diers JR; Bocian DF; Kaarsholm NC; Dunn MF Biopolymers; 2001; 62(5):249-60. PubMed ID: 11745120 [TBL] [Abstract][Full Text] [Related]
11. Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer. Jacoby E; Hua QX; Stern AS; Frank BH; Weiss MA J Mol Biol; 1996 Apr; 258(1):136-57. PubMed ID: 8613983 [TBL] [Abstract][Full Text] [Related]
12. Role of metal ions in the T- to R-allosteric transition in the insulin hexamer. Kadima W Biochemistry; 1999 Oct; 38(41):13443-52. PubMed ID: 10521251 [TBL] [Abstract][Full Text] [Related]
13. Spectroscopic evidence for an intermediate in the T6 to R6 allosteric transition of the Co(II)-substituted insulin hexamer. Gross L; Dunn MF Biochemistry; 1992 Feb; 31(5):1295-301. PubMed ID: 1736988 [TBL] [Abstract][Full Text] [Related]
14. Binding of 2,6- and 2,7-dihydroxynaphthalene to wild-type and E-B13Q insulins: dynamic, equilibrium, and molecular modeling investigations. Bloom CR; Heymann R; Kaarsholm NC; Dunn MF Biochemistry; 1997 Oct; 36(42):12746-58. PubMed ID: 9335531 [TBL] [Abstract][Full Text] [Related]
15. Structural signatures of the complex formed between 3-nitro-4-hydroxybenzoate and the Zn(II)-substituted R(6) insulin hexamer. Olsen HB; Leuenberger-Fisher MR; Kadima W; Borchardt D; Kaarsholm NC; Dunn MF Protein Sci; 2003 Sep; 12(9):1902-13. PubMed ID: 12930990 [TBL] [Abstract][Full Text] [Related]
16. The T to R transition in the copper(II)-substituted insulin hexamer. Anion complexes of the R-state species exhibiting type 1 and type 2 spectral characteristics. Brader ML; Borchardt D; Dunn MF Biochemistry; 1992 May; 31(19):4691-6. PubMed ID: 1316158 [TBL] [Abstract][Full Text] [Related]
17. Ligand binding and thermostability of different allosteric states of the insulin zinc-hexamer. Huus K; Havelund S; Olsen HB; Sigurskjold BW; van de Weert M; Frokjaer S Biochemistry; 2006 Mar; 45(12):4014-24. PubMed ID: 16548529 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding. Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591 [TBL] [Abstract][Full Text] [Related]
19. Solution structures of the R6 human insulin hexamer, Chang X; Jorgensen AM; Bardrum P; Led JJ Biochemistry; 1997 Aug; 36(31):9409-22. PubMed ID: 9235985 [TBL] [Abstract][Full Text] [Related]
20. Insulin allosteric behavior: detection, identification, and quantification of allosteric states via 19F NMR. Bonaccio M; Ghaderi N; Borchardt D; Dunn MF Biochemistry; 2005 May; 44(21):7656-68. PubMed ID: 15909980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]